A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection

Lv, Shuying; Wang, Lei; Zou, Xiaohui; Wang, Zihan; Qu, Baoquan; Lin, Wen Wei; Yang, Dingquan

doi:10.2147/ccid.s307982

Cited by 17 publications

(19 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…25 As shown in our results, the detailed trichoscopic findings reported across the studies most commonly included reduced hair density, 19,24,30 empty hair follicles, 9,24,25,30 short regrowing hair, 24,25 and/or hair in the telogen phase. 16,19 Similar to the findings of classic acute TE, there was a female preponderance (67.5%) in the patients diagnosed with acute TE post-COVID-19. This can be explained by the higher vulnerability of female hair follicles, easier identification of hair loss in females owing to longer hair, and under-reporting in males due to the higher psychological effects of hair loss in women.…”

Section: Management and Outcomes Of Acute Tesupporting

confidence: 57%

“…A total of 632 patients with a history of COVID-19 infection were included from 19 studies. 8,9,[14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30] Out of these 632 patients, 465 patients reported hair loss after recovery from COVID-19 and were subsequently diagnosed with acute TE. The median age of these patients was 44 years (which ranged from 34 to 64 years), with 67.5% of them being female.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

A systematic review of acute telogen effluvium, a harrowing post‐COVID‐19 manifestation

Hussain¹,

Agarwala

Iqbal

et al. 2021

Journal of Medical Virology

View full text Add to dashboard Cite

This systematic review focuses on the clinical features, physical examination findings, outcomes, and underlying pathology of acute telogen effluvium (TE), a type of diffuse hair loss, occurring in coronavirus disease 2019 (COVID‐19) recovered patients. MEDLINE/PubMed and Embase databases were queried till October 2021 to identify studies reporting acute TE occurring after COVID‐19 recovery. Data were obtained from 19 studies, which included 465 patients who were diagnosed with acute TE. The median age of these patients was 44 years and 67.5% were females. The most common trichoscopic findings were decreased hair density, the presence of empty follicles, or short regrowing hair. The mean duration from COVID‐19 symptom onset to the appearance of acute TE was 74 days, which is earlier than classic acute TE. Most patients recovered from hair loss, while a few patients had persistent hair fall. Our results highlight the need to consider the possibility of post‐COVID‐19 acute TE in patients presenting with hair fall, with a history of COVID‐19 infection, in the context of COVID‐19 pandemic. Despite being a self‐limiting condition, hair loss post‐COVID‐19 is a stressful manifestation. Identifying COVID‐19 infection as a potential cause of acute TE will help the clinicians counsel the patients, relieving them from undue stress.

show abstract

Section: Management and Outcomes Of Acute Tesupporting

confidence: 57%

Section: Resultsmentioning

confidence: 99%

A systematic review of acute telogen effluvium, a harrowing post‐COVID‐19 manifestation

Hussain¹,

Agarwala

Iqbal

et al. 2021

Journal of Medical Virology

View full text Add to dashboard Cite

show abstract

“…Additionally, 728 more cases of patients who developed TE after the diagnosis of COVID-19 have been described in Europe, the United States, and Asia [22][23][24][25][26][27][28][29][30][31] .…”

Section: Re Sultsmentioning

confidence: 99%

Hair and nail manifestations of COVID‐19

Tammaro

Adebanjo

Parisella

et al. 2022

J of Cosmetic Dermatology

View full text Add to dashboard Cite

Emerging literature evidence shows that the manifestations of the coronavirus disease 2019 (COVID‐19), which is the disease caused by SARS‐CoV‐2, encompass alterations of the pulmonary, cardiovascular, gastrointestinal, and neurological system. Moreover, hematologic and dermatologic manifestations have been documented. The aim of this review is to summarize the dermatologic manifestations of COVID‐19 involving the hair and nails in a narrative way. A total of 1136 patients have been reported to have de novo hair loss following COVID‐19. Notably, 958 patients experienced telogen effluvium (TE) (female/male ratio = 3,86:1), two female patients experienced anagen effluvium, and 176 people had alopecia areata (female/male ratio of 19:3). Ten patients were reported to have ungual changes following the infection with the novel coronavirus: The individuals affected were 6 women and 4 men. COVID‐19 can be associated with hair and ungual manifestations. This review summarizes the evidence regarding the hair and ungual manifestations of COVID‐19, which could be harnessed to better understand the clinical implications and pathophysiology of this disease that has been burdening society globally since December 2019.

show abstract

“…Telogen effluvium Telogen effluvium (coined "COVID scalp") depicting thinning of hair along midline part [192].…”

mentioning

confidence: 99%

“…Further investigations are needed to elucidate the underlying pathomechanism between SARS-CoV2 and TE. A,B) Telogen effluvium (coined "COVID scalp") depicting thinning of hair along midline part [192].…”

mentioning

confidence: 99%

The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review

et al. 2022

View full text Add to dashboard Cite

Background: The earliest cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, in December 2019. Since the declaration as a pandemic on 11 March 2020, further dermatological conditions continue to be documented. We herein present a novel literature review of dermatological manifestations associated with the Coronavirus Disease 2019 (COVID-19) pandemic. To date, this literature review is the first broad-spectrum examination that analyzes a range of dermatological manifestations related to the COVID-19 pandemic: infection, vaccinations, personal protective equipment (PPE), and psychosocial factors. Methods: A detailed literature search was conducted using key terms for cutaneous manifestations associated with the scope of this review. The search retrieved 2199 articles. Results: The COVID-19 pandemic has triggered a significant range of dermatologic sequela. Etiologies of lesions continue to be investigated. Proposed mechanisms include inflammatory response to spike protein, vitamin D deficiency, ACE2 receptor activation, androgen levels, and increased psychological stress. One prominent mechanism describes viral spike protein invasion into the dermis by binding to the angiotensin-converting enzyme 2 (ACE-2) receptors in keratinocytes, with a secondary immunological response. Conclusions: Dermatologists play an integral role in the proper diagnosis and treatment of COVID-related lesions. Early treatment regimens and timely prophylaxis have been shown to safely reduce infection-related dermatological sequelae. Additional investigations and data collection can reduce disease burden and improve overall prognosis.

show abstract

A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection

Abstract: As the number of COVID-19 cases increasing, more and more patients are concerning about alopecia, a sequela after SARS-CoV-2 infection. We here report a case of a 38-year-old woman with a typical acute telogen effluvium (ATE) after recovery from COVID-19.

Cited by 17 publications

References 9 publications

A systematic review of acute telogen effluvium, a harrowing post‐COVID‐19 manifestation

A systematic review of acute telogen effluvium, a harrowing post‐COVID‐19 manifestation

Hair and nail manifestations of COVID‐19

The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review

Contact Info

Product

Resources

About